These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 9832639

  • 1. Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy.
    Matsuda M, Shikata K, Wada J, Sugimoto H, Shikata Y, Kawasaki T, Makino H.
    Nephron; 1998 Dec; 80(4):408-13. PubMed ID: 9832639
    [Abstract] [Full Text] [Related]

  • 2. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy.
    Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M, Fujita T.
    Nephrol Dial Transplant; 1998 Aug; 13(8):1984-90. PubMed ID: 9719152
    [Abstract] [Full Text] [Related]

  • 3. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.
    Hisano S, Matsushita M, Fujita T, Endo Y, Takebayashi S.
    Am J Kidney Dis; 2001 Nov; 38(5):1082-8. PubMed ID: 11684563
    [Abstract] [Full Text] [Related]

  • 4. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
    Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha MR.
    J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis.
    Hisano S, Matsushita M, Fujita T, Iwasaki H.
    Am J Kidney Dis; 2005 Feb; 45(2):295-302. PubMed ID: 15685507
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C, Zhang XH, Zhang Y, Lint TF, Gewurz H.
    J Immunol; 1998 Mar 15; 160(6):3006-13. PubMed ID: 9510205
    [Abstract] [Full Text] [Related]

  • 10. Collectin11 and Complement Activation in IgA Nephropathy.
    Wei M, Guo WY, Xu BY, Shi SF, Liu LJ, Zhou XJ, Lv JC, Zhu L, Zhang H.
    Clin J Am Soc Nephrol; 2021 Dec 15; 16(12):1840-1850. PubMed ID: 34615657
    [Abstract] [Full Text] [Related]

  • 11. The Clinicopathologic Characteristics and Complement Activation of Antineutrophil Cytoplasmic Antibody-associated Vasculitides With Glomerular IgA Deposition.
    Ma Y, Chen L, Xu Y, Han Q, Yu B, Zhao J, Hua Z, Yang Y, Chen J, Han F.
    Appl Immunohistochem Mol Morphol; 2020 Dec 15; 28(10):e87-e93. PubMed ID: 31789820
    [Abstract] [Full Text] [Related]

  • 12. [Mannose-binding protein gene polymorphism influences the patterns of glomerular immune deposition in IgA nephropathy].
    Gong R, Liu Z, Chen Z, Liu D, Li L.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr 15; 18(2):83-7. PubMed ID: 11295122
    [Abstract] [Full Text] [Related]

  • 13. Complement activation through the lectin pathway in patients with Henoch-Schönlein purpura nephritis.
    Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M.
    Am J Kidney Dis; 2000 Mar 15; 35(3):401-7. PubMed ID: 10692265
    [Abstract] [Full Text] [Related]

  • 14. Jak3 expression in glomerular epithelia of IgA nephropathy (IgA-N) patients.
    Takahashi T, Shirasawa T, Miyake K, Yahagi Y, Matsumura O, Abe A, Natori Y, Yamabe H, Utsunomiya Y, Maruyama N, Mitarai T, Sakai O.
    Clin Exp Immunol; 1996 Jun 15; 104(3):517-24. PubMed ID: 9099938
    [Abstract] [Full Text] [Related]

  • 15. Role of complement in IgA nephropathy.
    Daha MR, van Kooten C.
    J Nephrol; 2016 Feb 15; 29(1):1-4. PubMed ID: 26567162
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy.
    Miyazaki R, Kuroda M, Akiyama T, Otani I, Tofuku Y, Takeda R.
    Clin Nephrol; 1984 Jun 15; 21(6):335-40. PubMed ID: 6205804
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Significance of glomerular deposition of C3c and C3d in IgA nephropathy.
    Nakagawa H, Suzuki S, Haneda M, Gejyo F, Kikkawa R.
    Am J Nephrol; 2000 Jun 15; 20(2):122-8. PubMed ID: 10773612
    [Abstract] [Full Text] [Related]

  • 20. [Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].
    Segarra A.
    Nefrologia; 2010 Jun 15; 30(5):501-7. PubMed ID: 20882091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.